Stockreport

Robust Analgesic Activity of Aptinyx’s NYX-2925 in Advanced DPN Patients Revealed Through Further Analysis of Data from Phase 2 Study

Aptinyx Inc.  (APTX) 
Last aptinyx inc. earnings: 3/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.aptinyx.com/investors-media
PDF Mechanism of NYX-2925 is highly relevant in advanced DPN patients with longer duration of chronic pain [Read more]